Does GILTERITINIB Cause Hepatic function abnormal? 181 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 181 reports of Hepatic function abnormal have been filed in association with GILTERITINIB (Xospata). This represents 4.9% of all adverse event reports for GILTERITINIB.
181
Reports of Hepatic function abnormal with GILTERITINIB
4.9%
of all GILTERITINIB reports
61
Deaths
93
Hospitalizations
How Dangerous Is Hepatic function abnormal From GILTERITINIB?
Of the 181 reports, 61 (33.7%) resulted in death, 93 (51.4%) required hospitalization, and 19 (10.5%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
Yes, Hepatic function abnormal is listed as a known adverse reaction in the official FDA drug label for GILTERITINIB.
What Other Side Effects Does GILTERITINIB Cause?
Acute myeloid leukaemia (366)
Febrile neutropenia (346)
Off label use (334)
Platelet count decreased (327)
Pneumonia (302)
Myelosuppression (300)
Pyrexia (281)
Death (206)
Product use issue (189)
Neutrophil count decreased (162)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which GILTERITINIB Alternatives Have Lower Hepatic function abnormal Risk?
GILTERITINIB vs GIMERACIL\OTERACIL\TEGAFUR
GILTERITINIB vs GINKGO
GILTERITINIB vs GIVINOSTAT
GILTERITINIB vs GIVOSIRAN
GILTERITINIB vs GLASDEGIB